Molecular genetic analysis of 675 group a Streptococcus isolates collected in a carrier study at Lackland Air Force Base, San Antonio, Texas

Journal of Infectious Diseases

Volumn 188, Issue 6, 2003, Pages 818-827

  Hoe, Nancy P ^a   Fullerton, Kathleen E ^a,e   Liu, Mengyao ^a   Peters, John E ^b   Gackstetter, Gary D ^c   Adams, Gerald J ^d   Musser, James M ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b McHenry County College   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR FORCE; ALLELE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; TRAINING; UNINDEXED SEQUENCE; UNITED STATES;

ALLELES; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CARRIER STATE; DNA, BACTERIAL; FEMALE; GENE FREQUENCY; HUMANS; MALE; MILITARY PERSONNEL; MOLECULAR SEQUENCE DATA; PHARYNGITIS; PHARYNX; POPULATION SURVEILLANCE; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TEXAS;

EID: 0141840766     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377644     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention. Group A streptococcal (GAS) disease. Available at: http://www.cdc.gov/ncidod/dbmd/disease-info/groupastreptococcal_t.htm.
2. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance report, Emerging Infections Program Network, group A Streptococcus, 2001. Available at: http://www.cdc.gov/ncidod/dbmd/abcs/survreports.htm.
3. Fischetti VA. Surface proteins on gram-positive bacteria. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, eds. Gram-positive pathogens. Washington, DC: American Society for Microbiology Press, 2000:11-24.
4. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A Streptococcus disease in the United Slates, 1995-1999. Clin Infect Dis 2002; 35:268-76.
5. Musser JM, Krause RM. The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. In: Krause RM, ed. Emerging infections. New York: Academic Press, 1998:185-218.
6. Cockerill FR III, MacDonald KL, Thompson RL, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 1997; 277:38-43.
7. Kiska DL, Thiede B, Caracciolo J, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176:992-1000.
8. Musser JM, Kapur V, Peters JE, et al. Real-time molecular epidemiologic analysis of an outbreak of Streptococcus pyogenes invasive disease in US Air Force trainees. Arch Pathol Lab Med 1994; 118:128-33.
9. Muotiala A, Seppala H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 1997; 175:392-9.
10. Hoe NP, Vuopio-Varkila J, Vaara M, et al. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis 2001; 183:633-9.
11. Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J Infect Dis 2002; 185:1586-95.
12. Kaplan EL, Wotton JT, lohnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet 2001; 358:1334-7.
13. Lukomski S, Hoe NP, Abdi I, et al. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 2000; 68:535-42.
14. Hoe NP, Ireland RM, DeLeo FR, et al. Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc Natl Acad Sci USA 2002; 99:7646-51.
15. Ji Y, Carlson B, Kondagunta A, Cleary PP. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect Immun 1997; 65:2080-7.
16. Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC. Respiratory diseases among US military personnel: countering emerging threats. Emerg Infect Dis 1999; 5:379-87.
17. Gunzenhauser JD, Longfield JN, Brundage JF, Kaplan EL, Miller RN, Brandt CA. Epidemic streptococcal disease among army trainees, July 1989 through June 1991. J Infect Dis 1995; 172:124-31.
18. Centers for Disease Control. Acute rheumatic fever among army trainees - Fort Leonard Wood, Missouri, 1987-1988. MMWR Morb Mortal Wkly Rep 1988; 37:519-22.
19. Centers for Disease Control. Acute rheumatic fever at a naval training center San Diego, CA. MMWR Morb Mortal Wkly Rep 1988; 37:101-4.
20. Krause RM, Rammelkamp CH Jr. Studies of the carrier state following infection with group A streptococci. II. Infectivity of streptococci isolated during acute pharyngitis and during the carrier state. J Clin Invest 1962; 41:575-8.
21. Gray GC, Escamilla J, Hyams KC, Struewing JP, Kaplan EL, Tupponce AK. Hyperendemic Streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine. N Engl J Med 1991; 325:92-7.
22. Heggie AD, Jacobs MR, Linz PE, Han DP, Kaplan EL, Boxerbaum B. Prevalence and characteristics of pharyngeal group A beta-hemolytic streptococci in US Navy recruits receiving benzathine penicillin prophylaxis. J Infect Dis 1992; 166:1006-13.
23. Hamburger M Jr, Green MJ, Hamburger VG. The problem of the "dangerous carrier" of hemolytic streptococci. I. Number of hemolytic streptococci expelled by carriers with positive and negative nose cultures. J Infect Dis 1945; 77:68-81.
24. Hamburger M Jr, Green MJ, Hamburger VG. The problem of the "dangerous carrier" of hemolytic streptococci. II. Spread of infection by individuals with strongly positive nose cultures who expelled large numbers of hemolytic streptococci. J Infect Dis 1945; 77:96-108.
25. Wannamaker LW. The epidemiology of streptococcal infections. In: McCarty M, ed. Streptococcal infections. New York: Columbia University Press, 1954:157-75.
26. Peters JE, Gackstetter GD. Streptococcus pyogenes transmission among Air Force recruits: efficacy of surveillance and prophylaxis protocols. Mil Med 1998; 163:667-71.
27. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63:994-1003.
28. Stockbauer KE, Grigsby D, Pan X, et al. Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci USA 1998; 95:3128-33.
29. Hoe NP, Nakashima K, Lukomski S, et al. Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med 1999; 5:924-9.
30. Perea Mejia LM, Stockbauer KE, Pan X, Cravioto A, Musser JM. Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein. J Clin Microbiol 1997; 35:3220-4.
31. Hollingshead SK, Fischetti VA, Scott JR. Complete nucleotide sequence of type 6 M protein of the group A Streptococcus: repetitive structure and membrane anchor. J Biol Chem 1986; 261:1677-86.
32. Akesson P, Sjöholm AG, Bjorck L. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 1996; 271:1081-8.
33. Hoe N, Nakashima K, Grigsby D, et al. Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg Infect Dis 1999; 5:254-63.
34. Matsumoto M, Hoe NP, Liu M, et al. Intrahost sequence variation in the streptococcal inhibitor of complement gene in human pharyngitis patients. J Infect Dis 2003; 187:604-12.
35. Kaplan EL, Johnson DR, Rehder CD. Recent changes in group A streptococcal serotypes from uncomplicated pharyngitis: a reflection of the changing epidemiology of severe group A infections? J Infect Dis 1994; 170:1346-7.
36. James WES, Badger GF, Dingle JH. A study of illness in a group of Cleveland families: XIX. The epidemiology of the acquisition of group A streptococci and of associated illnesses. N Engl J Med 1960; 262:687-94.
37. Maekawa S, Fukuda K, Yamauchi T, Yamaguchi T, Takahashi K, Sugawa K. Follow-up study of pharyngeal carriers of beta-hemolytic streptococci among school children in Sapporo city during a period of 2 years and 5 months. J Clin Microbiol 1981; 13:1017-22.
38. Anthony BF, Kaplan EL, Wannamaker LW, Chapman SS. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Am J Epidemiol 1976; 104:652-66.
39. Denny FW, Houser HB. Commission on streptococcal and staphylococcal diseases. In: Woodward TE, ed. The armed forces epidemiological board: history of the commissions. Washington, DC: Borden Institute, 1994:262-382.
40. Rammelkamp CH Jr. Epidemiology of streptococcal infections. Harvey Lect 1956; 51:113-42.
41. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA. Prevention of rheumatic fever by treatment of the preceding streptococcic infection. JAMA 1950; 143:151-3.
42. Levine JI, Chapman SS, Guerra V, Cooper J, Krause RM. Studies on the transmission within families of group A hemolytic streptococci. J Lab Clin Med 1966; 67:483-94.
43. Catanzaro FJ, Rammelkamp CHJ, Chamovitz R. Prevention of rheumatic fever by treatment of streptococcal infections. II. Factors responsible for failures. N Engl J Med 1958; 259:51-7.
44. Hoe NP, Lukomski S, Ireland RM, etaI. The hypervariable streptococcal inhibitor of complement, a virulence factor that inhibits group A Streptococcus adherence to host cells [abstract D-27] In: Program and abstracts of the 101st general meeting of the American Society of Microbiology (Orlando). Washington, DC: American Society, for Microbiology, 2001:280.
45. Sharkawy A, Low DE, Saginur R, et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34:454-60.
46. Suligoi B, Von Hunolstein C, Orefici G, Scopetti F, Pataracchia M, Greco D. Surveillance of systemic invasive disease caused by group A Streptococcus in Italy, 1994-1996. Eurosurveillance 1998; 3:11-4.
47. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45(Suppl):3-12.